Physician profile
Ivan S Alkes
NPI 1750466819
$1,935.44
in general payments reported to CMS, 2019-2025
22 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $292 · 2021: $246 · 2022: $106 · 2023: $85.23 · 2024: $221 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $376.92 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $279.80 | 2019-2024 | Mounjaro |
| Abbvie INC. | $198.07 | 2021-2024 | Ubrelvy |
| Allergan, INC. | $164.93 | 2019-2020 | |
| Exact Sciences Corporation | $138.87 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $121.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $118.89 | 2020-2025 | Cobenfy |
| Novartis Pharmaceuticals Corporation | $111.94 | 2019 | |
| Glaxosmithkline, LLC. | $95.10 | 2019-2025 | Arexvy |
| Astellas Pharma US INC | $48.30 | 2025 | Veozah |
| Eisai INC. | $46.48 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $38.83 | 2022 | |
| Pfizer INC. | $33.79 | 2021-2024 | |
| Novo Nordisk INC | $32.00 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $18.74 | 2022 | |
| Philips North America LLC | $18.21 | 2023 | |
| Urgo Medical North America, LLC | $17.60 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Abbott Laboratories | $13.42 | 2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $12.47 | 2021 | |
| Hologic Sales and Service, LLC | $11.97 | 2019 | |
| Sanofi Pasteur INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Alkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.